Author(s): Jardel G, Villarinho B, Kelly de V, Pinheirfrancielle D, Oliveira SM, Machado P, et al.
Neuropathic pain is a debilitating condition that is often resistant to common analgesics, such as opioids, but is sensitive to some antidepressants, an effect that seems to be mediated by spinal cord 5-HT3 receptors. Because the analgesic potential of monoamine oxidase-A (MAO-A) inhibitors is understudied, we evaluated the potential antinociceptive effect of the reversible MAO-A inhibitors moclobemide and 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in a mouse neuropathic pain model induced by chronic constriction injury (CCI) of the sciatic nerve. Neuropathic mice showed a decreased mechanical paw withdrawal threshold (PWT) 7 days after lesion compared with the baseline PWT, characterizing the development of hyperalgesia. Moclobemide (100-300 μmol/kg, s.c.) and 2-DMPI (30-300 μmol/kg, s.c.) treatments were able to reverse the CCI-induced hyperalgesia, with 50% inhibitory dose (ID50) values of 39 (18-84) and 11 (4-33) μmol/kg, and maximum inhibition (Imax) values of 88±14 and 98±15%, respectively, at the 300 μmol/kg dose. In addition, we observed a significant increase in the MAO-A activity in the lumbar spinal cord of CCI-submitted mice compared with sham-operated animals. Furthermore, the antihyperalgesic effects of both 2-DMPI and moclobemide were largely reversed by intrathecal injection of the 5-HT3 receptor antagonist ondansetron (10 μg/site). These results suggest a possible involvement of MAO-A in the mechanisms of neuropathic pain and a potential utility of the reversible inhibitors of MAO-A in the development of new therapeutic approaches to treat it.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/23419243
Author(s): Singh B, Kaur P, Gopichand, Singh RD, Ahuja PS
Author(s): Jang CH, Cho YB, Choi CH
Author(s): Qiu F, Friesen JB, McAlpine JB, Pauli GF
Author(s): Xiang Z, Wu-fang Z, Dong-feng Z, Chen da C, Xiu MH, et al.
Author(s): Abdel-Wahab BA, Abd El-Aziz SM
Author(s): Nada SE, Shah ZA
Author(s): He Z, Liao Y, Zheng M, Zeng FD, Guo LJ
Author(s): Osvaldo G , Giovanna P , Maria C
Author(s): Barreiro KA, Suárez LD, Lynch VM, Molina VA, Delorenzi A
Author(s): Luo YX, Xue YX, Shen HW, Lu L
Author(s): Thullier F, Lepelley MC, Lestienne FG
Author(s): Chen YN, Mitra S, Schlaghecken F
Author(s): Stahlhut L, Grotemeyer KH2, Husstedt IW1, Evers S3
Author(s): Szalma I, Kiss A, Kardos L, Horváth G, Nyitrai E, et al.
Author(s): Evans JG, Wilcock G, Birks J
Author(s): Chatterjie N, Alexander G, Wang H
Author(s): Güngör L, Terzi M, Onar MK
Author(s): Yang JF, Zhou DY, Liang ZY
Author(s): Ding S, Dudley E, Plummer S, Tang J, Newton RP, et al.
Author(s): Kotil K, Turgay B, Tugrul T, Ton T, Kucukhuseyin C, et al.
Author(s): Mahadevan S, Park Y
Author(s): Kennedy DO, Scholey AB, Wesnes KA
Author(s): Droy-Lefaix MT
Author(s): Ryu KH, Han HY, Lee SY, Jeon SD, Im GJ, et al.
Author(s): Cohen-Salmon C, Venault P, Martin B, Raffalli-Sébille MJ, Barkats M, et al.
Author(s): Persson J, Bringlöv E, Nilsson LG, Nyberg L
Author(s): Zhang SJ, Xue ZY
Author(s): García-Cabeza I, de Blas MM, Epifanio MM, de Chávez MG
Author(s): de Jongh R, Bolt I, Schermer M, Olivier B